OPHLF(OPHLF)
OPHLF
No analyst ratings available
No analyst price targets available for OPHLF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $451.95B | $442.82B | $456.33B | $486.15B | $485.65B |
| Low | $441.25B | $432.34B | $445.53B | $474.65B | $474.16B |
| High | $469.54B | $460.06B | $474.10B | $505.08B | $504.56B |
| EBITDA Avg | $139.81B | $136.99B | $141.17B | $150.39B | $150.24B |
| Low | $136.50B | $133.75B | $137.83B | $146.84B | $146.68B |
| High | $145.26B | $142.32B | $146.66B | $156.25B | $156.09B |
| EBIT Avg | $116.98B | $114.62B | $118.12B | $125.84B | $125.71B |
| Low | $114.21B | $111.91B | $115.32B | $122.86B | $122.73B |
| High | $121.54B | $119.08B | $122.72B | $130.73B | $130.60B |
| Net Income Avg | $69.66B | $62.36B | $65.66B | $73.12B | $65.14B |
| Low | $67.52B | $60.44B | $63.64B | $70.87B | $63.14B |
| High | $73.19B | $65.52B | $68.99B | $76.82B | $68.44B |
| EPS Avg | $148.23 | $132.69 | $139.72 | $155.59 | $138.61 |
| Low | $143.67 | $128.61 | $135.42 | $150.81 | $134.34 |
| High | $155.73 | $139.41 | $146.79 | $163.47 | $145.62 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 5 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $110.34B | $119.52B | $114.84B |
| Low | $107.37B | $116.31B | $111.75B |
| High | $114.03B | $123.52B | $118.68B |
| EBITDA Avg | $34.13B | $36.97B | $35.53B |
| Low | $33.22B | $35.98B | $34.57B |
| High | $35.28B | $38.21B | $36.71B |
| EBIT Avg | $28.56B | $30.94B | $29.72B |
| Low | $27.79B | $30.10B | $28.93B |
| High | $29.52B | $31.97B | $30.72B |
| Net Income Avg | $17.16B | $21.93B | $16.79B |
| Low | $16.56B | $21.16B | $16.20B |
| High | $17.90B | $22.88B | $17.52B |
| EPS Avg | $35.97 | $45.98 | $35.21 |
| Low | $34.72 | $44.38 | $33.98 |
| High | $37.54 | $47.99 | $36.74 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 |